Avalo Therapeutics, Inc.
AVTX
$19.50
$0.050.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 253.41% | -34.43% | -26.91% | 36.35% | 21.23% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 299.74% | 264.70% | 59.84% | -34.20% | -21.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 145.00% | 137.10% | 94.74% | 119.51% | -- |
| Total Current Assets | 254.15% | -30.03% | -24.19% | 32.15% | 20.12% |
|
|
|||||
| Total Current Assets | 254.15% | -30.03% | -24.19% | 32.15% | 20.12% |
| Net Property, Plant & Equipment | -58.02% | -60.48% | -61.95% | -67.62% | -61.46% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.86% | 39.69% | 60.31% | 60.31% | 60.31% |
| Total Assets | 287.72% | -27.89% | -22.74% | 27.06% | 16.87% |
|
|
|||||
| Total Accounts Payable | 41.46% | -47.72% | -51.59% | -73.83% | 261.77% |
| Total Accrued Expenses | 32.72% | 195.88% | 137.99% | 88.34% | 52.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -49.79% | -37.64% | -30.99% | -20.36% | -12.04% |
| Total Finance Division Other Current Liabilities | 1,271.74% | -- | -- | -99.47% | -99.20% |
| Total Other Current Liabilities | 1,271.74% | -- | -- | -99.47% | -99.20% |
| Total Current Liabilities | 128.21% | 106.57% | 85.92% | -86.86% | -90.39% |
|
|
|||||
| Total Current Liabilities | 128.21% | 106.57% | 85.92% | -86.86% | -90.39% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -90.00% | -89.20% | -83.35% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 67.23% | 99.30% | 96.67% | 82.35% | -2.52% |
| Total Liabilities | 91.39% | 98.42% | 88.75% | -55.69% | -80.07% |
|
|
|||||
| Common Stock & APIC | 87.46% | 6.02% | 5.60% | 47.84% | 47.75% |
| Retained Earnings | -24.82% | -22.10% | -21.14% | -29.82% | -12.91% |
| Treasury Stock & Other | -1,614.71% | -- | -- | -- | -- |
| Total Common Equity | 329.04% | -44.28% | -37.57% | 334.37% | 868.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 329.04% | -44.28% | -37.57% | 334.37% | 868.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 329.04% | -44.28% | -37.57% | 302.69% | 4,961.65% |
|
|
|||||